Enjaymo Europese Unie - Hongaars - EMA (European Medicines Agency)

enjaymo

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunszuppresszánsok - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

Spevigo Europese Unie - Hongaars - EMA (European Medicines Agency)

spevigo

boehringer ingelheim international gmbh - spesolimab - pikkelysömör - immunszuppresszánsok - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

Ebglyss Europese Unie - Hongaars - EMA (European Medicines Agency)

ebglyss

almirall, s.a. - lebrikizumab - dermatitis, atopic - egyéb bőrgyógyászati ​​készítmények - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.